AEGLE THERAPEUTICS
Company Snapshot
Founded: 2013
Entity Type: Private
Region: U.S.
Headquarter: Massachusetts, U.S.
Key Geographics: U.S.
Corporate Address: 400 TradeCenter, Suite 5900 Woburn, Massachusetts 01801 U.S. www.aegletherapeutics.com
Company Overview
Aegle Therapeutics is a clinical-stage biotechnology company developing a series of novel therapeutics in regenerative medicine based on its proprietary extracellular vesicles (EVs) isolation technology. Its patented EV harvesting/isolation technology, exclusively licensed from the University of Miami, allows the company to gently isolate EVs from mesenchymal stem cells (MSCs) without damaging or modifying them. Its MSC-EVs therapy is being developed to treat various indications in multiple therapeutic areas, including dermatology, immunology-based diseases, protein-deficient disorders, etc.
AEGLE THERAPEUTICS In Reports
AEGLE THERAPEUTICS In News
Company's Business Segments
- Extracellular Vesicle : This technology safely isolates native Extracellular Vesicles from Stem Cells. These EVs carry complex assemblies of Biologic Molecules such as Proteins, Nucleic Acids.
Applications/End User Industries
- Stem Cells
- Biotechnology
- Dermatology
- Immunology
- Extracellular Vesicle
- Life Sciences